Alpha memo: resveratrol exercise animal-disease-to-aged-men endpoint boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Reframe the research question to name the specific transfer being bounded, e.g., 'Does the combined resveratrol+exercise cardiac/aortic benefit observed in 3xTg mice transfer to skeletal muscle metabolic/inflammatory endpoints in aged men?'
2. Correct the overclaim that Receipt 2 fully 'separates the components'; Receipt 2 tests resveratrol alone vs. exercise+resveratrol vs. exercise+placebo, and the headline finding is that resveratrol alone (and resveratrol added to exercise) did not augment exercise's effect. The memo should report this design honestly.
3. Tighten the title or the body so they align: either rename to emphasize the combined-vs-isolated protocol contrast, or add an explicit caveat in the title that Receipt 1 cannot isolate resveratrol's contribution.
4. Note the truncated Receipt 1 excerpt and avoid quoting aortic/cardiac findings as fully excerpt-supported when the excerpt is cut off mid-sentence.

Major issues

• The research question as posed ('How far does the Receipt 1 signal transfer across the setting tested by Receipt 2?') is meta-level and vague; it does not name the specific endpoint or population transfer being bounded, leaving the bounded contrast underspecified for a reader who does not already know the receipts.
• Title says 'resveratrol exercise animal-disease-to-aged-men endpoint boundary' but the memo's central bounded contrast is between a combined-protocol animal-disease receipt and a single-component-isolation human receipt; the 'boundary' framing obscures that Receipt 1 cannot attribute signal to resveratrol alone, weakening the title's implied resveratrol-specific claim.

Minor issues

• Receipt 2's design actually includes a combined resveratrol + exercise arm, so the memo's claim that Receipt 2 'separates the components' overstates the receipt's single-component isolation; resveratrol alone was tested, but exercise+resveratrol was also tested and the excerpt does not show the combined arm was null.
• The excerpt for Receipt 1 is truncated mid-sentence ('filling ve'), and the memo does not note this truncation when citing the aortic/cardiac findings.
• The 'Why this is surprising' section restates the boundary rather than articulating why the contrast is non-obvious against prior literature.
• Domain slug 'longevity_research' is a stretch: neither receipt is framed as longevity research; both are cardiovascular/skeletal muscle physiology with disease-model or aging contexts.

Reviewer note

The memo correctly identifies a real contrast between two receipts: a 2019 3xTg mouse study reporting combined resveratrol+exercise effects on cardiac/aortic measures, and a 2014 aged-men RCT showing exercise but not resveratrol improved skeletal muscle metabolic/inflammatory markers. The source-grounding is strong: both DOIs and excerpts match, citations are accurate, and the falsifier is appropriately narrow. The main weaknesses are (1) the research question is framed meta-level rather than specifying the transfer being tested, and (2) the memo overstates Receipt 2's ability to 'separate the components' — the receipt's design includes a resveratrol+exercise arm, so resveratrol's null effect is properly read as 'no additive benefit over exercise' rather than 'resveratrol tested in isolation.' The title's 'resveratrol exercise animal-disease-to-aged-men endpoint boundary' implies a resveratrol-specific transfer, but Receipt 1 cannot isolate resveratrol's contribution from the combined protocol, creating a title/body mismatch that is fixable with a rename or an explicit caveat. The limitation and gap sections are concrete and actionable (matched-design study identified as the falsifier), and the bounded-contrast axes are clearly enumerated. With the revisions above — particularly correcting the 'separates the components' overclaim and sharpening the research question — this memo would be accept-quality. In current form it is competent but fixable.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis